SignalFDA/Bio

Roche multiple sclerosis pill gets FDA priority review

FDA priority review accelerates Roche's multiple sclerosis pill toward potential approval.

What changed

FDA priority review accelerates Roche's multiple sclerosis pill toward potential approval.

Why it matters

FDA priority review accelerates Roche's multiple sclerosis pill toward potential approval. — impact context not separately stored; see What changed.

Sources